These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2434612)

  • 1. Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine.
    Waters JA; O'Rourke SM; Richardson SC; Papaevangelou G; Thomas HC
    J Med Virol; 1987 Feb; 21(2):155-60. PubMed ID: 2434612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of recombinant hepatitis B vaccine.
    Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine study.
    Heijtink RA; Kruining J; Schalm SW; Masurel N
    J Virol Methods; 1985 Apr; 10(4):333-9. PubMed ID: 2581987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to recombinant and plasma derived hepatitis B vaccines.
    Brown SE; Stanley C; Howard CR; Zuckerman AJ; Steward MW
    Br Med J (Clin Res Ed); 1986 Jan; 292(6514):159-61. PubMed ID: 3080114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen.
    McMahon BJ; Parkinson AJ; Helminiak C; Wainwright RB; Bulkow L; Kellerman-Douglas A; Schoenberg S; Ritter D
    Gastroenterology; 1992 Aug; 103(2):590-4. PubMed ID: 1386048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines.
    Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.
    Leroux-Roels G; Van Hecke E; Michielsen W; Voet P; Hauser P; Pêtre J
    Vaccine; 1994 Jul; 12(9):812-8. PubMed ID: 7975860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
    Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP
    Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.
    Heijtink RA; van Bergen P; Paulij WP; de Man RA; Osterhaus AD
    Vaccine; 2000 Feb; 18(15):1531-8. PubMed ID: 10618551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences.
    Tron F; Degos F; Bréchot C; Couroucé AM; Goudeau A; Marie FN; Adamowicz P; Saliou P; Laplanche A; Benhamou JP
    J Infect Dis; 1989 Aug; 160(2):199-204. PubMed ID: 2527274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
    Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
    J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast recombinant hepatitis B vaccine.
    Hilleman MR
    Infection; 1987; 15(1):3-7. PubMed ID: 2437037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and immunological analysis of recombinant hepatitis B vaccine.
    Emini EA; Ellis RW; Miller WJ; McAleer WJ; Scolnick EM; Gerety RJ
    J Infect; 1986 Jul; 13 Suppl A():3-9. PubMed ID: 2427590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
    Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
    JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of T cell epitopes on hepatitis B surface antigen.
    Vento S
    Ann Ist Super Sanita; 1991; 27(1):37-40. PubMed ID: 1720295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccine.
    Zoulek G; Lorbeer B; Jilg W; Deinhardt F
    Lancet; 1984 Oct; 2(8409):983-4. PubMed ID: 6149374
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological properties of recombinant HBsAg produced in yeast.
    Hauser P; Voet P; Simoen E; Thomas HC; Pêtre J; De Wilde M; Stephenne J
    Postgrad Med J; 1987; 63 Suppl 2():83-91. PubMed ID: 2446304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Limited value of anti-HBs determination following vaccination against hepatitis B].
    Heijtink RA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(33):1443-4. PubMed ID: 2959868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.